Spotlight

Hyper-Sensitive qPCR

The first company to develop a singlicate testing qPCR assay for BCR-ABL with a sensitivity level that empowers physicians to monitor Complete Molecular Response in patients with CML*. The MR4.7 sensitivity attained, illustrates Asuragen’s ability to combine advanced proprietary bioinformatics with unique qPCR chemistry expertise to produce an assay that enables a significant change in clinical practice.

*CE-IVD and US export only.

Learn more about our qPCR assay for BCR-ABL:
QuantideX qPCR BCR-ABL IS CE-IVD Kit

View the full poster

Back To
Top

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close